Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Haematologica|April 13, 2004
Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literatureGerald Jäger, Gerald Höfler, Werner Linkesch, et al.Biochemical and Biophysical Research Communications|May 28, 2003
An apparent decrease in cholesterol biosynthesis in peroxisomal-defective Chinese hamster ovary cells is related to impaired mitochondrial oxidationKarl Oettl, Gerald Höfler, Gene C Ness, et al.Journal of Cutaneous Pathology|April 26, 2002
Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia (B-CLL) at sites typical for Borrelia burgdorferi infectionLorenzo Cerroni, Gerald Höfler, Barbara Bäck, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 29, 2008
Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteerSanja Schuller-Petrovic, Gerald Wölkart, Gerald Höfler, et al.Archives of Orthopaedic and Trauma Surgery|March 20, 2025
Evaluation of the implementation of the minimally invasive emergency procedure REBOA via an open surgical approach in a teaching unit - a cadaveric studyPeter Grechenig, Barbara Hallmann, Nicolas Eibinger, et al.European Journal of Haematology|September 25, 2002
Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II studyGerald Jäeger, Peter Neumeister, Ruth Brezinschek, et al.Pediatric Transplantation|April 14, 2007
Durable remission following a third allogeneic stem cell transplantation in a patient with repeatedly relapsing SAA. The importance of stroma cells for sustained engraftment?Daniela Weber-Mzell, Christian Urban, Martin Benesch, et al.European Journal of Gastroenterology & Hepatology|March 1, 2003
Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571): effect of low dosage in an advanced tumour with exon 11 mutationChristoph Högenauer, Cord Langner, Rainer W Lipp, et al.Scientific Reports|April 20, 2024
Percutaneous ultrasound-guided versus open cut-down access to femoral vessels for the placement of a REBOA catheterPeter Grechenig, Barbara Hallmann, Nicolas Rene Eibinger, et al.Blood|January 5, 2002
Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosisChristine Beham-Schmid, Ute Apfelbeck, Heinz Sill, et al.Pageof 4